Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 3
1956 1
1958 1
1959 1
1960 1
1963 1
1964 1
1965 4
1969 1
1971 2
1973 2
1974 12
1975 8
1976 7
1977 6
1978 3
1979 4
1980 2
1981 2
1982 5
1983 4
1984 8
1985 7
1986 3
1987 6
1988 3
1989 2
1990 4
1992 3
1993 4
1994 3
1995 2
1996 6
1997 7
1998 4
1999 3
2000 3
2001 2
2002 7
2003 5
2004 11
2005 5
2006 6
2007 7
2008 9
2009 5
2010 8
2011 12
2012 10
2013 11
2014 18
2015 13
2016 8
2017 15
2018 19
2019 13
2020 24
2021 24
2022 23
2023 18
2024 12
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

381 results

Results by year

Filters applied: . Clear all
Page 1
Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study.
Hosomi Y, Morita S, Sugawara S, Kato T, Fukuhara T, Gemma A, Takahashi K, Fujita Y, Harada T, Minato K, Takamura K, Hagiwara K, Kobayashi K, Nukiwa T, Inoue A; North-East Japan Study Group. Hosomi Y, et al. Among authors: takamura k. J Clin Oncol. 2020 Jan 10;38(2):115-123. doi: 10.1200/JCO.19.01488. Epub 2019 Nov 4. J Clin Oncol. 2020. PMID: 31682542 Clinical Trial.
A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study).
Watanabe S, Furuya N, Nakamura A, Shiihara J, Nakachi I, Tanaka H, Nakao M, Minato K, Seike M, Sasaki S, Kisohara A, Takeuchi S, Honda R, Takamura K, Kagamu H, Yoshimura K, Kobayashi K, Kikuchi T. Watanabe S, et al. Among authors: takamura k. Eur J Cancer. 2024 Jan;197:113469. doi: 10.1016/j.ejca.2023.113469. Epub 2023 Dec 2. Eur J Cancer. 2024. PMID: 38061214 Clinical Trial.
Real-world data on the efficacy and safety of immune-checkpoint inhibitors in elderly patients with non-small cell lung cancer.
Morinaga D, Asahina H, Ito S, Honjo O, Tanaka H, Honda R, Yokouchi H, Nakamura K, Takamura K, Hommura F, Kawai Y, Ito K, Sukoh N, Yokoo K, Morita R, Harada T, Takashina T, Goda T, Dosaka-Akita H, Isobe H; Hokkaido Lung Cancer Clinical Study Group Trial. Morinaga D, et al. Among authors: takamura k. Cancer Med. 2023 May;12(10):11525-11541. doi: 10.1002/cam4.5889. Epub 2023 Mar 31. Cancer Med. 2023. PMID: 36999734 Free PMC article.
Complications after metal-on-metal hip resurfacing arthroplasty.
Amstutz HC, Le Duff MJ, Campbell PA, Wisk LE, Takamura KM. Amstutz HC, et al. Among authors: takamura km. Orthop Clin North Am. 2011 Apr;42(2):207-30, viii. doi: 10.1016/j.ocl.2010.12.002. Orthop Clin North Am. 2011. PMID: 21435496 Review.
Applicable predictive factors extracted from peak flow trajectory for the prediction of asthma exacerbation.
Yang Y, Kimura H, Yokota I, Makita H, Takimoto-Sato M, Matsumoto-Sasaki M, Matsumoto M, Oguma A, Abe Y, Takei N, Goudarzi H, Shimizu K, Suzuki M, Nishimura M, Konno S; Hi-CARAT investigators. Yang Y, et al. Ann Allergy Asthma Immunol. 2024 Apr;132(4):469-476. doi: 10.1016/j.anai.2023.11.015. Epub 2023 Nov 24. Ann Allergy Asthma Immunol. 2024. PMID: 38006971 Clinical Trial.
Poor Nutritional Status during Recovery from Acute Myocardial Infarction in Patients without an Early Nutritional Intervention Predicts a Poor Prognosis: A Single-Center Retrospective Study.
Abe H, Miyazaki T, Tomaru M, Nobushima Y, Ajima T, Hirabayashi K, Ishiwata S, Kakihara M, Maki M, Shimai R, Aikawa T, Isogai H, Ozaki D, Yasuda Y, Odagiri F, Takamura K, Hiki M, Iwata H, Yokoyama K, Tokano T, Minamino T. Abe H, et al. Among authors: takamura k. Nutrients. 2023 Nov 10;15(22):4748. doi: 10.3390/nu15224748. Nutrients. 2023. PMID: 38004141 Free PMC article.
Association between Immune-Related Adverse Events and Atezolizumab in Previously Treated Patients with Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer.
Hayashi H, Nishio M, Akamatsu H, Goto Y, Miura S, Gemma A, Yoshino I, Misumi T, Kijima T, Takase N, Fujita M, Tasaka S, Mouri A, Kondo T, Takamura K, Kawashima Y, Imaizumi K, Iwasawa S, Nakagawa S, Mitsudomi T. Hayashi H, et al. Among authors: takamura k. Cancer Res Commun. 2024 Nov 1;4(11):2858-2867. doi: 10.1158/2767-9764.CRC-24-0212. Cancer Res Commun. 2024. PMID: 39392339 Free PMC article.
381 results